Drug Carriers for Vascular Drug Delivery

被引:28
作者
Koren, Erez [1 ]
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Dept Pharmaceut Sci, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA
关键词
vascular targeting; endothelial cells; drug delivery; pharmaceutical nanocarriers; MYOCARDIAL-INFARCTION; TUMOR VASCULATURE; CANCER-THERAPY; LIPOSOMES; ANTIBODY; NANOCARRIERS; ADHESION; AGENTS; THERAPEUTICS; PHYSIOLOGY;
D O I
10.1002/iub.496
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The currently used drug carriers for vascular drug delivery are reviewed. The human vascular system possesses unique physiological features that can be exploited for enhanced and effective targeted drug delivery. Although the thin layer of endothelial cells (EC) lines the interior surface of blood vessels forming an interface between circulating blood in the lumen and the tissue beyond the vessel wall, it can also function as a target for drugs to EC in different vascular areas. ECs overexpress specific cell-surface molecules under various pathological conditions (tumor neovasculature, inflammation, oxidative stress, and thrombosis), which are absent or barely detectable in established normal blood vessels. By coupling unique endothelial surface markers, such as antibodies, specific peptides, and growth factors to a variety of drug carriers, effective active vascular-targeted drug delivery systems can be achieved. This review focuses on the recent advances and strategies for effective targeted vascular drug delivery using a variety of drug-loaded carriers along with new targeting approaches that can be used in the design and optimization of such carriers. (C) 2011 IUBMB IUBMB Life, 63(8): 586-595, 2011
引用
收藏
页码:586 / 595
页数:10
相关论文
共 48 条
[1]   Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes [J].
Abu Lila, Amr S. ;
Ishida, Tatsuhiro ;
Kiwada, Hiroshi .
PHARMACEUTICAL RESEARCH, 2010, 27 (07) :1171-1183
[2]   Designing gene delivery vectors for cardiovascular gene therapy [J].
Baker, AH .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2004, 84 (2-3) :279-299
[3]   Cell-mediated drug delivery [J].
Batrakova, Elena V. ;
Gendelman, Howard E. ;
Kabanov, Alexander V. .
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) :415-433
[4]   ANTIBODY-DIRECTED UROKINASE - A SPECIFIC FIBRINOLYTIC AGENT [J].
BODE, C ;
MATSUEDA, GR ;
HUI, KY ;
HABER, E .
SCIENCE, 1985, 229 (4715) :765-767
[5]   Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment [J].
Cairns, R ;
Papandreou, I ;
Denko, N .
MOLECULAR CANCER RESEARCH, 2006, 4 (02) :61-70
[6]   Targeted nanocarriers for imaging and therapy of vascular inflammation [J].
Chacko, Ann-Marie ;
Hood, Elizabeth D. ;
Zern, Blaine J. ;
Muzykantov, Vladimir R. .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2011, 16 (03) :215-227
[7]  
Cines DB, 1998, BLOOD, V91, P3527
[8]   Cell adhesion molecules for targeted drug delivery [J].
Dunehoo, Alison L. ;
Anderson, Meagan ;
Majumdar, Sumit ;
Kobayashi, Naoki ;
Berkland, Cory ;
Siahaan, Teruna J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) :1856-1872
[9]   Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway [J].
Erbacher, P ;
Remy, JS ;
Behr, JP .
GENE THERAPY, 1999, 6 (01) :138-145
[10]  
FREEMAN BA, 1985, FED PROC, V44, P2591